Changes to medication-use processes after overdose of U-500 regular insulin

American Journal of Health-System Pharmacy

Volumn 69, Issue 23, 2012, Pages 2089-2093

  Monroe, P Sayer ^a   Heck, Wendy D ^a   Lavsa, Stacey M ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; GLUCOSE; INSULIN GLARGINE; INSULIN LISPRO; PIG INSULIN;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADVANCED PRACTICE NURSE; AGED; ARTICLE; CANCER CHEMOTHERAPY; CASE REPORT; CLINICAL PRACTICE; DRUG OVERDOSE; DRUG SAFETY; DRUG USE; GLUCOSE BLOOD LEVEL; HUMAN; MALE; MEDICAL SERVICE; MEDICATION ERROR; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT CARE; PATIENT EDUCATION; PATIENT MONITORING; PHARMACIST; PHYSICIAN; PRESCRIPTION; PRIORITY JOURNAL; SYRINGE; UNSPECIFIED SIDE EFFECT;

EID: 84869754593     PISSN: 10792082     EISSN: 15352900     Source Type: Journal    
DOI: 10.2146/ajhp110628     Document Type: Article

References (9)

1. Van den Berghe G, Wouters P, Weekers F et al. Intensive insulin therapy in critically ill patients. N Engl J Med. 2001; 345:1359-67.
2. Van den Berghe G, Wilmer A, Hermans G et al. Intensive insulin therapy in the medical ICU. N Engl J Med. 2006; 354:449-61.
3. Cohen MR. Pharmacists' role in ensuring safe and effective hospital use of insulin. Am J Health-Syst Pharm. 2010; 67(suppl 8):S17-21.
4. Institute for Safe Medication Practices. ISMP's list of high-alert medications. www.ismp.org/newsletters/acutecare/articles/20031201.asp (accessed 2012 Jul 16).
5. Joint Commission. Hospital Accreditation Standards 2011. www.joint commission.org/standards-information/editon.aspx (accessed 2011 Aug 15).
6. Ballani P, Tran MT, Navar MD et al. Clinical experience with U-500 regular insulin in obese, markedly insulin resistant type 2 diabetic patients. Diabetes Care. 2006; 29: 2504-5.
7. Lane WS, Cochran EK, Jackson JA et al. High-dose insulin therapy: is it time for U-500 insulin? Endocr Pract. 2009; 15:71-9.
8. Samaan KH, Dahlke M, Stover J. Addressing safety concerns about U-500 insulin in a hospital setting. Am J Health-Syst Pharm. 2011; 68:63-8.
9. Segal AR, Brunner JE, Burch FT et al. Use of concentrated insulin human regular (U-500) for patient with diabetes. Am J Health-Syst Pharm. 2010; 67:1526-35.